임광범 (Boston Children's Hospital, Harvard Medical School) | 한빛사논문 > 한빛사

한빛사논문

조회80

임광범Gwang-Bum Im

Boston Children's Hospital, Harvard Medical School

Cell Metab., Volume 38, Issue 6, 2 June 2026, Pages 1081-1084 | https://doi.org/10.1016/j.cmet.2026.04.017 [Commentary] Intercellular mitochondrial transfer in disease: Therapeutic opportunity or driver of tumor progression?

Gwang-Bum Im ^{1 2 *}, Juan M. Melero-Martin ^{1 2 3 *}

¹Department of Cardiac Surgery, Boston Children’s Hospital, Boston, MA 02115, USA
²Department of Surgery, Harvard Medical School, Boston, MA 02115, USA
³Harvard Stem Cell Institute, Cambridge, MA 02138, USA

^*Corresponding authors: correspondence to Gwang-Bum Im or Juan M. Melero-Martin

Abstract

Intercellular mitochondrial transfer has emerged as a key mode of metabolic communication across tissues. Its outcomes are context dependent, spanning from therapeutic benefits to pathological risks.

논문정보